Global iPSC-Derived Neural Progenitor Cells Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global iPSC-Derived Neural Progenitor Cells market size was valued at US$ 74.08 million in 2025 and is forecast to a readjusted size of US$ 202 million by 2032 with a CAGR of 15.2% during review period.
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer?s disease, Parkinson?s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
This report is a detailed and comprehensive analysis for global iPSC-Derived Neural Progenitor Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC-Derived Neural Progenitor Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
iPSC-Derived Neural Progenitor Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe iPSC-Derived Neural Progenitor Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of iPSC-Derived Neural Progenitor Cells, with price, sales quantity, revenue, and global market share of iPSC-Derived Neural Progenitor Cells from 2021 to 2026.
Chapter 3, the iPSC-Derived Neural Progenitor Cells competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the iPSC-Derived Neural Progenitor Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and iPSC-Derived Neural Progenitor Cells market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of iPSC-Derived Neural Progenitor Cells.
Chapter 14 and 15, to describe iPSC-Derived Neural Progenitor Cells sales channel, distributors, customers, research findings and conclusion.
iPSC-Derived Neural Progenitor Cells (NPCs) are neural stem/progenitor cell products generated from human induced pluripotent stem cells (iPSCs) through directed neural induction. These cells can further differentiate into neurons, astrocytes, and oligodendrocytes. They are typically supplied as cryopreserved cells, cell-plus-media kits, differentiation reagent systems, and customized cell lines. These products are widely used in neurodevelopmental research, disease modeling, drug screening, and early-stage regenerative medicine research. The overall gross margin is approximately 62%.
Demand for iPSC-derived NPCs is primarily driven by applications in neurological disease modeling, developmental neurotoxicity assessment, and high-content drug screening. Compared with primary neural cells, iPSC-derived NPCs offer traceable sourcing, scalable expansion, and customizable donor or genetic backgrounds, enabling broad coverage of research areas such as Alzheimer?s disease, Parkinson?s disease, ALS, autism spectrum disorders, and drug-induced neurotoxicity. As pharmaceutical companies increasingly reduce reliance on animal models and seek more human-relevant early safety assessment tools, demand for standardized NPC products continues to expand in both usage frequency and project scope.
Product development is focused on improving region-specific differentiation stability, disease-specific or gene-edited backgrounds, xeno-free culture systems, and ready-to-use assay formats. Leading suppliers are extending offerings beyond cryopreserved cells to integrated solutions combining cells, culture media, and differentiation protocols, while also developing organoid systems, co-culture models, and high-throughput compatible readouts. However, the market is still constrained by batch-to-batch variability, incomplete maturation control, limited long-term expansion stability, and variability in post-thaw recovery performance. Companies with high-quality cell banks, strict QC standards, and well-validated application datasets are more likely to be adopted by pharmaceutical and CRO customers.
Regionally, North America and Europe remain the primary markets for research and drug screening applications, while China, Japan, and South Korea are increasing investments in iPSC platforms, neurodegenerative disease research, and translational cell therapy programs. In the short term, demand is concentrated in research-grade and screening-grade products. Long-term growth is expected to come from GMP-compatible cell products, preclinical safety validation systems, and support for neuroregenerative therapeutic pipelines.
Report Scope
This report is a detailed and comprehensive analysis for global iPSC-Derived Neural Progenitor Cells market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC-Derived Neural Progenitor Cells market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global iPSC-Derived Neural Progenitor Cells market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for iPSC-Derived Neural Progenitor Cells
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
iPSC-Derived Neural Progenitor Cells market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Cryopreserved Cells
- Cell and Media Kits
- Differentiation Kits
- Disease-Specific Cells
- Custom or GMP-Compatible Cells
- Other Formats
- Healthy Control Donor
- Patient-Derived Disease Model
- Gene-Edited Reporter Line
- Immune-Matched or HLA Line
- Custom Donor Background
- Other Donor Background
- Neural Stem Cells
- Neural Progenitor Cells
- Regional Neural Progenitors
- Lineage-Committed Progenitors
- Mature Neural Derivatives
- Other Differentiation Stages
- Research Use Only Grade
- Assay-Ready Grade
- Xeno-Free Defined Grade
- GMP-Compatible Grade
- Custom Validated Grade
- Other Quality Grades
- Neurological Disease Modeling
- Neurotoxicity and Safety Testing
- Drug Screening and Target Validation
- Neural Differentiation and Organoid Culture
- Regenerative Medicine Research
- Other Applications
- STEMCELL Technologies
- Merck
- Applied StemCell
- Axol Bioscience
- Tempo Bioscience
- Creative Bioarray
- ACROBiosystems
- ATCC
- Cell Applications
- AcceGen
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe iPSC-Derived Neural Progenitor Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of iPSC-Derived Neural Progenitor Cells, with price, sales quantity, revenue, and global market share of iPSC-Derived Neural Progenitor Cells from 2021 to 2026.
Chapter 3, the iPSC-Derived Neural Progenitor Cells competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the iPSC-Derived Neural Progenitor Cells breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and iPSC-Derived Neural Progenitor Cells market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of iPSC-Derived Neural Progenitor Cells.
Chapter 14 and 15, to describe iPSC-Derived Neural Progenitor Cells sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Cryopreserved Cells
1.3.3 Cell and Media Kits
1.3.4 Differentiation Kits
1.3.5 Disease-Specific Cells
1.3.6 Custom or GMP-Compatible Cells
1.3.7 Other Formats
1.4 Market Analysis by Donor or Disease Background
1.4.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Donor or Disease Background: 2021 Versus 2025 Versus 2032
1.4.2 Healthy Control Donor
1.4.3 Patient-Derived Disease Model
1.4.4 Gene-Edited Reporter Line
1.4.5 Immune-Matched or HLA Line
1.4.6 Custom Donor Background
1.4.7 Other Donor Background
1.5 Market Analysis by Differentiation Stage
1.5.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Differentiation Stage: 2021 Versus 2025 Versus 2032
1.5.2 Neural Stem Cells
1.5.3 Neural Progenitor Cells
1.5.4 Regional Neural Progenitors
1.5.5 Lineage-Committed Progenitors
1.5.6 Mature Neural Derivatives
1.5.7 Other Differentiation Stages
1.6 Market Analysis by Quality Grade
1.6.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Quality Grade: 2021 Versus 2025 Versus 2032
1.6.2 Research Use Only Grade
1.6.3 Assay-Ready Grade
1.6.4 Xeno-Free Defined Grade
1.6.5 GMP-Compatible Grade
1.6.6 Custom Validated Grade
1.6.7 Other Quality Grades
1.7 Market Analysis by Application
1.7.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Neurological Disease Modeling
1.7.3 Neurotoxicity and Safety Testing
1.7.4 Drug Screening and Target Validation
1.7.5 Neural Differentiation and Organoid Culture
1.7.6 Regenerative Medicine Research
1.7.7 Other Applications
1.8 Global iPSC-Derived Neural Progenitor Cells Market Size & Forecast
1.8.1 Global iPSC-Derived Neural Progenitor Cells Consumption Value (2021 & 2025 & 2032)
1.8.2 Global iPSC-Derived Neural Progenitor Cells Sales Quantity (2021-2032)
1.8.3 Global iPSC-Derived Neural Progenitor Cells Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 STEMCELL Technologies
2.1.1 STEMCELL Technologies Details
2.1.2 STEMCELL Technologies Major Business
2.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
2.1.4 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 STEMCELL Technologies Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck iPSC-Derived Neural Progenitor Cells Product and Services
2.2.4 Merck iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merck Recent Developments/Updates
2.3 Applied StemCell
2.3.1 Applied StemCell Details
2.3.2 Applied StemCell Major Business
2.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
2.3.4 Applied StemCell iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Applied StemCell Recent Developments/Updates
2.4 Axol Bioscience
2.4.1 Axol Bioscience Details
2.4.2 Axol Bioscience Major Business
2.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
2.4.4 Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Axol Bioscience Recent Developments/Updates
2.5 Tempo Bioscience
2.5.1 Tempo Bioscience Details
2.5.2 Tempo Bioscience Major Business
2.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
2.5.4 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Tempo Bioscience Recent Developments/Updates
2.6 Creative Bioarray
2.6.1 Creative Bioarray Details
2.6.2 Creative Bioarray Major Business
2.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
2.6.4 Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Bioarray Recent Developments/Updates
2.7 ACROBiosystems
2.7.1 ACROBiosystems Details
2.7.2 ACROBiosystems Major Business
2.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
2.7.4 ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ACROBiosystems Recent Developments/Updates
2.8 ATCC
2.8.1 ATCC Details
2.8.2 ATCC Major Business
2.8.3 ATCC iPSC-Derived Neural Progenitor Cells Product and Services
2.8.4 ATCC iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ATCC Recent Developments/Updates
2.9 Cell Applications
2.9.1 Cell Applications Details
2.9.2 Cell Applications Major Business
2.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
2.9.4 Cell Applications iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cell Applications Recent Developments/Updates
2.10 AcceGen
2.10.1 AcceGen Details
2.10.2 AcceGen Major Business
2.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
2.10.4 AcceGen iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 AcceGen Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IPSC-DERIVED NEURAL PROGENITOR CELLS BY MANUFACTURER
3.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Manufacturer (2021-2026)
3.2 Global iPSC-Derived Neural Progenitor Cells Revenue by Manufacturer (2021-2026)
3.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 iPSC-Derived Neural Progenitor Cells Manufacturer Market Share in 2025
3.4.3 Top 6 iPSC-Derived Neural Progenitor Cells Manufacturer Market Share in 2025
3.5 iPSC-Derived Neural Progenitor Cells Market: Overall Company Footprint Analysis
3.5.1 iPSC-Derived Neural Progenitor Cells Market: Region Footprint
3.5.2 iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
3.5.3 iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global iPSC-Derived Neural Progenitor Cells Market Size by Region
4.1.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2032)
4.1.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2032)
4.1.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2032)
4.2 North America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.3 Europe iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.4 Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.5 South America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.6 Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
5.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2021-2032)
5.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
6.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2021-2032)
6.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
7.2 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
7.3 North America iPSC-Derived Neural Progenitor Cells Market Size by Country
7.3.1 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
7.3.2 North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
8.2 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
8.3 Europe iPSC-Derived Neural Progenitor Cells Market Size by Country
8.3.1 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
8.3.2 Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific iPSC-Derived Neural Progenitor Cells Market Size by Region
9.3.1 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
10.2 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
10.3 South America iPSC-Derived Neural Progenitor Cells Market Size by Country
10.3.1 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
10.3.2 South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa iPSC-Derived Neural Progenitor Cells Market Size by Country
11.3.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 iPSC-Derived Neural Progenitor Cells Market Drivers
12.2 iPSC-Derived Neural Progenitor Cells Market Restraints
12.3 iPSC-Derived Neural Progenitor Cells Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of iPSC-Derived Neural Progenitor Cells and Key Manufacturers
13.2 Manufacturing Costs Percentage of iPSC-Derived Neural Progenitor Cells
13.3 iPSC-Derived Neural Progenitor Cells Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 iPSC-Derived Neural Progenitor Cells Typical Distributors
14.3 iPSC-Derived Neural Progenitor Cells Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Cryopreserved Cells
1.3.3 Cell and Media Kits
1.3.4 Differentiation Kits
1.3.5 Disease-Specific Cells
1.3.6 Custom or GMP-Compatible Cells
1.3.7 Other Formats
1.4 Market Analysis by Donor or Disease Background
1.4.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Donor or Disease Background: 2021 Versus 2025 Versus 2032
1.4.2 Healthy Control Donor
1.4.3 Patient-Derived Disease Model
1.4.4 Gene-Edited Reporter Line
1.4.5 Immune-Matched or HLA Line
1.4.6 Custom Donor Background
1.4.7 Other Donor Background
1.5 Market Analysis by Differentiation Stage
1.5.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Differentiation Stage: 2021 Versus 2025 Versus 2032
1.5.2 Neural Stem Cells
1.5.3 Neural Progenitor Cells
1.5.4 Regional Neural Progenitors
1.5.5 Lineage-Committed Progenitors
1.5.6 Mature Neural Derivatives
1.5.7 Other Differentiation Stages
1.6 Market Analysis by Quality Grade
1.6.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Quality Grade: 2021 Versus 2025 Versus 2032
1.6.2 Research Use Only Grade
1.6.3 Assay-Ready Grade
1.6.4 Xeno-Free Defined Grade
1.6.5 GMP-Compatible Grade
1.6.6 Custom Validated Grade
1.6.7 Other Quality Grades
1.7 Market Analysis by Application
1.7.1 Overview: Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Neurological Disease Modeling
1.7.3 Neurotoxicity and Safety Testing
1.7.4 Drug Screening and Target Validation
1.7.5 Neural Differentiation and Organoid Culture
1.7.6 Regenerative Medicine Research
1.7.7 Other Applications
1.8 Global iPSC-Derived Neural Progenitor Cells Market Size & Forecast
1.8.1 Global iPSC-Derived Neural Progenitor Cells Consumption Value (2021 & 2025 & 2032)
1.8.2 Global iPSC-Derived Neural Progenitor Cells Sales Quantity (2021-2032)
1.8.3 Global iPSC-Derived Neural Progenitor Cells Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 STEMCELL Technologies
2.1.1 STEMCELL Technologies Details
2.1.2 STEMCELL Technologies Major Business
2.1.3 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
2.1.4 STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 STEMCELL Technologies Recent Developments/Updates
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck iPSC-Derived Neural Progenitor Cells Product and Services
2.2.4 Merck iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Merck Recent Developments/Updates
2.3 Applied StemCell
2.3.1 Applied StemCell Details
2.3.2 Applied StemCell Major Business
2.3.3 Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
2.3.4 Applied StemCell iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Applied StemCell Recent Developments/Updates
2.4 Axol Bioscience
2.4.1 Axol Bioscience Details
2.4.2 Axol Bioscience Major Business
2.4.3 Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
2.4.4 Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Axol Bioscience Recent Developments/Updates
2.5 Tempo Bioscience
2.5.1 Tempo Bioscience Details
2.5.2 Tempo Bioscience Major Business
2.5.3 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
2.5.4 Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Tempo Bioscience Recent Developments/Updates
2.6 Creative Bioarray
2.6.1 Creative Bioarray Details
2.6.2 Creative Bioarray Major Business
2.6.3 Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
2.6.4 Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Bioarray Recent Developments/Updates
2.7 ACROBiosystems
2.7.1 ACROBiosystems Details
2.7.2 ACROBiosystems Major Business
2.7.3 ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
2.7.4 ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ACROBiosystems Recent Developments/Updates
2.8 ATCC
2.8.1 ATCC Details
2.8.2 ATCC Major Business
2.8.3 ATCC iPSC-Derived Neural Progenitor Cells Product and Services
2.8.4 ATCC iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ATCC Recent Developments/Updates
2.9 Cell Applications
2.9.1 Cell Applications Details
2.9.2 Cell Applications Major Business
2.9.3 Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
2.9.4 Cell Applications iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Cell Applications Recent Developments/Updates
2.10 AcceGen
2.10.1 AcceGen Details
2.10.2 AcceGen Major Business
2.10.3 AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
2.10.4 AcceGen iPSC-Derived Neural Progenitor Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 AcceGen Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IPSC-DERIVED NEURAL PROGENITOR CELLS BY MANUFACTURER
3.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Manufacturer (2021-2026)
3.2 Global iPSC-Derived Neural Progenitor Cells Revenue by Manufacturer (2021-2026)
3.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 iPSC-Derived Neural Progenitor Cells Manufacturer Market Share in 2025
3.4.3 Top 6 iPSC-Derived Neural Progenitor Cells Manufacturer Market Share in 2025
3.5 iPSC-Derived Neural Progenitor Cells Market: Overall Company Footprint Analysis
3.5.1 iPSC-Derived Neural Progenitor Cells Market: Region Footprint
3.5.2 iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
3.5.3 iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global iPSC-Derived Neural Progenitor Cells Market Size by Region
4.1.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2032)
4.1.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2032)
4.1.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2032)
4.2 North America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.3 Europe iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.4 Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.5 South America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
4.6 Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
5.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2021-2032)
5.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
6.2 Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2021-2032)
6.3 Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
7.2 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
7.3 North America iPSC-Derived Neural Progenitor Cells Market Size by Country
7.3.1 North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
7.3.2 North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
8.2 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
8.3 Europe iPSC-Derived Neural Progenitor Cells Market Size by Country
8.3.1 Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
8.3.2 Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific iPSC-Derived Neural Progenitor Cells Market Size by Region
9.3.1 Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
10.2 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
10.3 South America iPSC-Derived Neural Progenitor Cells Market Size by Country
10.3.1 South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
10.3.2 South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa iPSC-Derived Neural Progenitor Cells Market Size by Country
11.3.1 Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 iPSC-Derived Neural Progenitor Cells Market Drivers
12.2 iPSC-Derived Neural Progenitor Cells Market Restraints
12.3 iPSC-Derived Neural Progenitor Cells Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of iPSC-Derived Neural Progenitor Cells and Key Manufacturers
13.2 Manufacturing Costs Percentage of iPSC-Derived Neural Progenitor Cells
13.3 iPSC-Derived Neural Progenitor Cells Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 iPSC-Derived Neural Progenitor Cells Typical Distributors
14.3 iPSC-Derived Neural Progenitor Cells Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Table 3. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Table 4. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Quality Grade, (USD Million), 2021 & 2025 & 2032
Table 5. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. STEMCELL Technologies Basic Information, Manufacturing Base and Competitors
Table 7. STEMCELL Technologies Major Business
Table 8. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
Table 9. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. STEMCELL Technologies Recent Developments/Updates
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck iPSC-Derived Neural Progenitor Cells Product and Services
Table 14. Merck iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Merck Recent Developments/Updates
Table 16. Applied StemCell Basic Information, Manufacturing Base and Competitors
Table 17. Applied StemCell Major Business
Table 18. Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
Table 19. Applied StemCell iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Applied StemCell Recent Developments/Updates
Table 21. Axol Bioscience Basic Information, Manufacturing Base and Competitors
Table 22. Axol Bioscience Major Business
Table 23. Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 24. Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Axol Bioscience Recent Developments/Updates
Table 26. Tempo Bioscience Basic Information, Manufacturing Base and Competitors
Table 27. Tempo Bioscience Major Business
Table 28. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 29. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Tempo Bioscience Recent Developments/Updates
Table 31. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 32. Creative Bioarray Major Business
Table 33. Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
Table 34. Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Creative Bioarray Recent Developments/Updates
Table 36. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 37. ACROBiosystems Major Business
Table 38. ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
Table 39. ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. ACROBiosystems Recent Developments/Updates
Table 41. ATCC Basic Information, Manufacturing Base and Competitors
Table 42. ATCC Major Business
Table 43. ATCC iPSC-Derived Neural Progenitor Cells Product and Services
Table 44. ATCC iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. ATCC Recent Developments/Updates
Table 46. Cell Applications Basic Information, Manufacturing Base and Competitors
Table 47. Cell Applications Major Business
Table 48. Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
Table 49. Cell Applications iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Cell Applications Recent Developments/Updates
Table 51. AcceGen Basic Information, Manufacturing Base and Competitors
Table 52. AcceGen Major Business
Table 53. AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
Table 54. AcceGen iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. AcceGen Recent Developments/Updates
Table 56. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 57. Global iPSC-Derived Neural Progenitor Cells Revenue by Manufacturer (2021-2026) & (USD Million)
Table 58. Global iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 59. Market Position of Manufacturers in iPSC-Derived Neural Progenitor Cells, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 60. Head Office and iPSC-Derived Neural Progenitor Cells Production Site of Key Manufacturer
Table 61. iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
Table 62. iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
Table 63. iPSC-Derived Neural Progenitor Cells New Market Entrants and Barriers to Market Entry
Table 64. iPSC-Derived Neural Progenitor Cells Mergers, Acquisition, Agreements, and Collaborations
Table 65. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 66. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2026) & (K Dose)
Table 67. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2027-2032) & (K Dose)
Table 68. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 69. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2027-2032) & (USD Million)
Table 70. Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2026) & (US$/Dose)
Table 71. Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2027-2032) & (US$/Dose)
Table 72. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 73. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 74. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2021-2026) & (USD Million)
Table 75. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2027-2032) & (USD Million)
Table 76. Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2026) & (US$/Dose)
Table 77. Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2027-2032) & (US$/Dose)
Table 78. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 79. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 80. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2021-2026) & (USD Million)
Table 81. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2027-2032) & (USD Million)
Table 82. Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2026) & (US$/Dose)
Table 83. Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2027-2032) & (US$/Dose)
Table 84. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 85. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 86. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 87. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 88. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 89. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 90. North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 91. North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 93. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 94. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 95. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 96. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 97. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 98. Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 99. Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 101. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 102. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 103. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 104. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2026) & (K Dose)
Table 105. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2027-2032) & (K Dose)
Table 106. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 109. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 110. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 111. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 112. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 113. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 114. South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 115. South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 117. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 118. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 119. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 120. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 121. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 122. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 123. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 124. iPSC-Derived Neural Progenitor Cells Raw Material
Table 125. Key Manufacturers of iPSC-Derived Neural Progenitor Cells Raw Materials
Table 126. iPSC-Derived Neural Progenitor Cells Typical Distributors
Table 127. iPSC-Derived Neural Progenitor Cells Typical Customers
Table 1. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Table 3. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Table 4. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Quality Grade, (USD Million), 2021 & 2025 & 2032
Table 5. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. STEMCELL Technologies Basic Information, Manufacturing Base and Competitors
Table 7. STEMCELL Technologies Major Business
Table 8. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Product and Services
Table 9. STEMCELL Technologies iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. STEMCELL Technologies Recent Developments/Updates
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck iPSC-Derived Neural Progenitor Cells Product and Services
Table 14. Merck iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Merck Recent Developments/Updates
Table 16. Applied StemCell Basic Information, Manufacturing Base and Competitors
Table 17. Applied StemCell Major Business
Table 18. Applied StemCell iPSC-Derived Neural Progenitor Cells Product and Services
Table 19. Applied StemCell iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Applied StemCell Recent Developments/Updates
Table 21. Axol Bioscience Basic Information, Manufacturing Base and Competitors
Table 22. Axol Bioscience Major Business
Table 23. Axol Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 24. Axol Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Axol Bioscience Recent Developments/Updates
Table 26. Tempo Bioscience Basic Information, Manufacturing Base and Competitors
Table 27. Tempo Bioscience Major Business
Table 28. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Product and Services
Table 29. Tempo Bioscience iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Tempo Bioscience Recent Developments/Updates
Table 31. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 32. Creative Bioarray Major Business
Table 33. Creative Bioarray iPSC-Derived Neural Progenitor Cells Product and Services
Table 34. Creative Bioarray iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Creative Bioarray Recent Developments/Updates
Table 36. ACROBiosystems Basic Information, Manufacturing Base and Competitors
Table 37. ACROBiosystems Major Business
Table 38. ACROBiosystems iPSC-Derived Neural Progenitor Cells Product and Services
Table 39. ACROBiosystems iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. ACROBiosystems Recent Developments/Updates
Table 41. ATCC Basic Information, Manufacturing Base and Competitors
Table 42. ATCC Major Business
Table 43. ATCC iPSC-Derived Neural Progenitor Cells Product and Services
Table 44. ATCC iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. ATCC Recent Developments/Updates
Table 46. Cell Applications Basic Information, Manufacturing Base and Competitors
Table 47. Cell Applications Major Business
Table 48. Cell Applications iPSC-Derived Neural Progenitor Cells Product and Services
Table 49. Cell Applications iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Cell Applications Recent Developments/Updates
Table 51. AcceGen Basic Information, Manufacturing Base and Competitors
Table 52. AcceGen Major Business
Table 53. AcceGen iPSC-Derived Neural Progenitor Cells Product and Services
Table 54. AcceGen iPSC-Derived Neural Progenitor Cells Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. AcceGen Recent Developments/Updates
Table 56. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 57. Global iPSC-Derived Neural Progenitor Cells Revenue by Manufacturer (2021-2026) & (USD Million)
Table 58. Global iPSC-Derived Neural Progenitor Cells Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 59. Market Position of Manufacturers in iPSC-Derived Neural Progenitor Cells, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 60. Head Office and iPSC-Derived Neural Progenitor Cells Production Site of Key Manufacturer
Table 61. iPSC-Derived Neural Progenitor Cells Market: Company Product Type Footprint
Table 62. iPSC-Derived Neural Progenitor Cells Market: Company Product Application Footprint
Table 63. iPSC-Derived Neural Progenitor Cells New Market Entrants and Barriers to Market Entry
Table 64. iPSC-Derived Neural Progenitor Cells Mergers, Acquisition, Agreements, and Collaborations
Table 65. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 66. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2026) & (K Dose)
Table 67. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2027-2032) & (K Dose)
Table 68. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 69. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2027-2032) & (USD Million)
Table 70. Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2021-2026) & (US$/Dose)
Table 71. Global iPSC-Derived Neural Progenitor Cells Average Price by Region (2027-2032) & (US$/Dose)
Table 72. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 73. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 74. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2021-2026) & (USD Million)
Table 75. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Type (2027-2032) & (USD Million)
Table 76. Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2026) & (US$/Dose)
Table 77. Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2027-2032) & (US$/Dose)
Table 78. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 79. Global iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 80. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2021-2026) & (USD Million)
Table 81. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application (2027-2032) & (USD Million)
Table 82. Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2026) & (US$/Dose)
Table 83. Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2027-2032) & (US$/Dose)
Table 84. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 85. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 86. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 87. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 88. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 89. North America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 90. North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 91. North America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 92. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 93. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 94. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 95. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 96. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 97. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 98. Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 99. Europe iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 101. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 102. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 103. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 104. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2021-2026) & (K Dose)
Table 105. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity by Region (2027-2032) & (K Dose)
Table 106. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 109. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 110. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 111. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 112. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 113. South America iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 114. South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 115. South America iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2021-2026) & (K Dose)
Table 117. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Type (2027-2032) & (K Dose)
Table 118. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2021-2026) & (K Dose)
Table 119. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Application (2027-2032) & (K Dose)
Table 120. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2021-2026) & (K Dose)
Table 121. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity by Country (2027-2032) & (K Dose)
Table 122. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2021-2026) & (USD Million)
Table 123. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value by Country (2027-2032) & (USD Million)
Table 124. iPSC-Derived Neural Progenitor Cells Raw Material
Table 125. Key Manufacturers of iPSC-Derived Neural Progenitor Cells Raw Materials
Table 126. iPSC-Derived Neural Progenitor Cells Typical Distributors
Table 127. iPSC-Derived Neural Progenitor Cells Typical Customers
LIST OF FIGURES
Figure 1. iPSC-Derived Neural Progenitor Cells Picture
Figure 2. Global iPSC-Derived Neural Progenitor Cells Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Type in 2025
Figure 4. Cryopreserved Cells Examples
Figure 5. Cell and Media Kits Examples
Figure 6. Differentiation Kits Examples
Figure 7. Disease-Specific Cells Examples
Figure 8. Custom or GMP-Compatible Cells Examples
Figure 9. Other Formats Examples
Figure 10. Global iPSC-Derived Neural Progenitor Cells Revenue by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Figure 11. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Donor or Disease Background in 2025
Figure 12. Healthy Control Donor Examples
Figure 13. Patient-Derived Disease Model Examples
Figure 14. Gene-Edited Reporter Line Examples
Figure 15. Immune-Matched or HLA Line Examples
Figure 16. Custom Donor Background Examples
Figure 17. Other Donor Background Examples
Figure 18. Global iPSC-Derived Neural Progenitor Cells Revenue by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Figure 19. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Differentiation Stage in 2025
Figure 20. Neural Stem Cells Examples
Figure 21. Neural Progenitor Cells Examples
Figure 22. Regional Neural Progenitors Examples
Figure 23. Lineage-Committed Progenitors Examples
Figure 24. Mature Neural Derivatives Examples
Figure 25. Other Differentiation Stages Examples
Figure 26. Global iPSC-Derived Neural Progenitor Cells Revenue by Quality Grade, (USD Million), 2021 & 2025 & 2032
Figure 27. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Quality Grade in 2025
Figure 28. Research Use Only Grade Examples
Figure 29. Assay-Ready Grade Examples
Figure 30. Xeno-Free Defined Grade Examples
Figure 31. GMP-Compatible Grade Examples
Figure 32. Custom Validated Grade Examples
Figure 33. Other Quality Grades Examples
Figure 34. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application in 2025
Figure 36. Neurological Disease Modeling Examples
Figure 37. Neurotoxicity and Safety Testing Examples
Figure 38. Drug Screening and Target Validation Examples
Figure 39. Neural Differentiation and Organoid Culture Examples
Figure 40. Regenerative Medicine Research Examples
Figure 41. Other Applications Examples
Figure 42. Global iPSC-Derived Neural Progenitor Cells Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 43. Global iPSC-Derived Neural Progenitor Cells Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 44. Global iPSC-Derived Neural Progenitor Cells Sales Quantity (2021-2032) & (K Dose)
Figure 45. Global iPSC-Derived Neural Progenitor Cells Price (2021-2032) & (US$/Dose)
Figure 46. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Manufacturer in 2025
Figure 47. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Manufacturer in 2025
Figure 48. Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 49. Top 3 iPSC-Derived Neural Progenitor Cells Manufacturer (Revenue) Market Share in 2025
Figure 50. Top 6 iPSC-Derived Neural Progenitor Cells Manufacturer (Revenue) Market Share in 2025
Figure 51. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Region (2021-2032)
Figure 52. Global iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Region (2021-2032)
Figure 53. North America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 56. South America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 57. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 58. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 59. Global iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Type (2021-2032)
Figure 60. Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032) & (US$/Dose)
Figure 61. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 62. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application (2021-2032)
Figure 63. Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032) & (US$/Dose)
Figure 64. North America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 65. North America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 66. North America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 67. North America iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 68. United States iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 69. Canada iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 70. Mexico iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 71. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 72. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 73. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 74. Europe iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 75. Germany iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 76. France iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 77. United Kingdom iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 78. Russia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 79. Italy iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 80. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 81. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 82. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Region (2021-2032)
Figure 83. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Region (2021-2032)
Figure 84. China iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 85. Japan iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 86. South Korea iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 87. India iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 88. Southeast Asia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 89. Australia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 90. South America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 91. South America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 92. South America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 93. South America iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 94. Brazil iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 95. Argentina iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 96. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 97. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 98. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 99. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 100. Turkey iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 101. Egypt iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 102. Saudi Arabia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 103. South Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 104. iPSC-Derived Neural Progenitor Cells Market Drivers
Figure 105. iPSC-Derived Neural Progenitor Cells Market Restraints
Figure 106. iPSC-Derived Neural Progenitor Cells Market Trends
Figure 107. Porters Five Forces Analysis
Figure 108. Manufacturing Cost Structure Analysis of iPSC-Derived Neural Progenitor Cells in 2025
Figure 109. Manufacturing Process Analysis of iPSC-Derived Neural Progenitor Cells
Figure 110. iPSC-Derived Neural Progenitor Cells Industrial Chain
Figure 111. Sales Channel: Direct to End-User vs Distributors
Figure 112. Direct Channel Pros & Cons
Figure 113. Indirect Channel Pros & Cons
Figure 114. Methodology
Figure 115. Research Process and Data Source
Figure 1. iPSC-Derived Neural Progenitor Cells Picture
Figure 2. Global iPSC-Derived Neural Progenitor Cells Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Type in 2025
Figure 4. Cryopreserved Cells Examples
Figure 5. Cell and Media Kits Examples
Figure 6. Differentiation Kits Examples
Figure 7. Disease-Specific Cells Examples
Figure 8. Custom or GMP-Compatible Cells Examples
Figure 9. Other Formats Examples
Figure 10. Global iPSC-Derived Neural Progenitor Cells Revenue by Donor or Disease Background, (USD Million), 2021 & 2025 & 2032
Figure 11. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Donor or Disease Background in 2025
Figure 12. Healthy Control Donor Examples
Figure 13. Patient-Derived Disease Model Examples
Figure 14. Gene-Edited Reporter Line Examples
Figure 15. Immune-Matched or HLA Line Examples
Figure 16. Custom Donor Background Examples
Figure 17. Other Donor Background Examples
Figure 18. Global iPSC-Derived Neural Progenitor Cells Revenue by Differentiation Stage, (USD Million), 2021 & 2025 & 2032
Figure 19. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Differentiation Stage in 2025
Figure 20. Neural Stem Cells Examples
Figure 21. Neural Progenitor Cells Examples
Figure 22. Regional Neural Progenitors Examples
Figure 23. Lineage-Committed Progenitors Examples
Figure 24. Mature Neural Derivatives Examples
Figure 25. Other Differentiation Stages Examples
Figure 26. Global iPSC-Derived Neural Progenitor Cells Revenue by Quality Grade, (USD Million), 2021 & 2025 & 2032
Figure 27. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Quality Grade in 2025
Figure 28. Research Use Only Grade Examples
Figure 29. Assay-Ready Grade Examples
Figure 30. Xeno-Free Defined Grade Examples
Figure 31. GMP-Compatible Grade Examples
Figure 32. Custom Validated Grade Examples
Figure 33. Other Quality Grades Examples
Figure 34. Global iPSC-Derived Neural Progenitor Cells Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 35. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application in 2025
Figure 36. Neurological Disease Modeling Examples
Figure 37. Neurotoxicity and Safety Testing Examples
Figure 38. Drug Screening and Target Validation Examples
Figure 39. Neural Differentiation and Organoid Culture Examples
Figure 40. Regenerative Medicine Research Examples
Figure 41. Other Applications Examples
Figure 42. Global iPSC-Derived Neural Progenitor Cells Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 43. Global iPSC-Derived Neural Progenitor Cells Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 44. Global iPSC-Derived Neural Progenitor Cells Sales Quantity (2021-2032) & (K Dose)
Figure 45. Global iPSC-Derived Neural Progenitor Cells Price (2021-2032) & (US$/Dose)
Figure 46. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Manufacturer in 2025
Figure 47. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Manufacturer in 2025
Figure 48. Producer Shipments of iPSC-Derived Neural Progenitor Cells by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 49. Top 3 iPSC-Derived Neural Progenitor Cells Manufacturer (Revenue) Market Share in 2025
Figure 50. Top 6 iPSC-Derived Neural Progenitor Cells Manufacturer (Revenue) Market Share in 2025
Figure 51. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Region (2021-2032)
Figure 52. Global iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Region (2021-2032)
Figure 53. North America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 55. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 56. South America iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 57. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 58. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 59. Global iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Type (2021-2032)
Figure 60. Global iPSC-Derived Neural Progenitor Cells Average Price by Type (2021-2032) & (US$/Dose)
Figure 61. Global iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 62. Global iPSC-Derived Neural Progenitor Cells Revenue Market Share by Application (2021-2032)
Figure 63. Global iPSC-Derived Neural Progenitor Cells Average Price by Application (2021-2032) & (US$/Dose)
Figure 64. North America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 65. North America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 66. North America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 67. North America iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 68. United States iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 69. Canada iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 70. Mexico iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 71. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 72. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 73. Europe iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 74. Europe iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 75. Germany iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 76. France iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 77. United Kingdom iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 78. Russia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 79. Italy iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 80. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 81. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 82. Asia-Pacific iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Region (2021-2032)
Figure 83. Asia-Pacific iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Region (2021-2032)
Figure 84. China iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 85. Japan iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 86. South Korea iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 87. India iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 88. Southeast Asia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 89. Australia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 90. South America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 91. South America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 92. South America iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 93. South America iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 94. Brazil iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 95. Argentina iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 96. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Type (2021-2032)
Figure 97. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Application (2021-2032)
Figure 98. Middle East & Africa iPSC-Derived Neural Progenitor Cells Sales Quantity Market Share by Country (2021-2032)
Figure 99. Middle East & Africa iPSC-Derived Neural Progenitor Cells Consumption Value Market Share by Country (2021-2032)
Figure 100. Turkey iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 101. Egypt iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 102. Saudi Arabia iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 103. South Africa iPSC-Derived Neural Progenitor Cells Consumption Value (2021-2032) & (USD Million)
Figure 104. iPSC-Derived Neural Progenitor Cells Market Drivers
Figure 105. iPSC-Derived Neural Progenitor Cells Market Restraints
Figure 106. iPSC-Derived Neural Progenitor Cells Market Trends
Figure 107. Porters Five Forces Analysis
Figure 108. Manufacturing Cost Structure Analysis of iPSC-Derived Neural Progenitor Cells in 2025
Figure 109. Manufacturing Process Analysis of iPSC-Derived Neural Progenitor Cells
Figure 110. iPSC-Derived Neural Progenitor Cells Industrial Chain
Figure 111. Sales Channel: Direct to End-User vs Distributors
Figure 112. Direct Channel Pros & Cons
Figure 113. Indirect Channel Pros & Cons
Figure 114. Methodology
Figure 115. Research Process and Data Source
